Collins S J, Robertson K A, Mueller L
Molecular Medicine Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Mol Cell Biol. 1990 May;10(5):2154-63. doi: 10.1128/mcb.10.5.2154-2163.1990.
Retinoic acid (RA) induces terminal granulocytic differentiation of the HL-60 promyelocytic leukemia cell line as well as certain other human myeloid leukemias. Specific RA receptors that are members of the steroid-thyroid hormone superfamily of nuclear transcription factors have recently been identified. We developed an HL-60 subclone that was relatively resistant to RA-induced differentiation. Specific nuclear RA receptors in this RA-resistant subclone had a decreased affinity for RA and exhibited a lower molecular weight compared with nuclear RA receptors from the RA-sensitive parental HL-60 cells. Retroviral vector-mediated transduction of a single copy of the RA receptor (RAR-alpha) into this RA-resistant HL-60 subclone restored the sensitivity of these cells to RA. These observations indicate that RAR-alpha plays a critical and central role in mediating RA-induced terminal differentiation of HL-60 leukemia cells.
维甲酸(RA)可诱导HL-60早幼粒细胞白血病细胞系以及某些其他人类髓系白血病的终末粒细胞分化。最近已鉴定出属于核转录因子类固醇-甲状腺激素超家族成员的特异性RA受体。我们构建了一个对RA诱导分化相对耐药的HL-60亚克隆。与来自RA敏感的亲本HL-60细胞的核RA受体相比,该RA耐药亚克隆中的特异性核RA受体对RA的亲和力降低,且分子量较低。通过逆转录病毒载体介导将单拷贝的RA受体(RAR-α)转导到该RA耐药的HL-60亚克隆中,可恢复这些细胞对RA的敏感性。这些观察结果表明,RAR-α在介导RA诱导的HL-60白血病细胞终末分化中起关键核心作用。